{"id":50020,"date":"2022-10-25T11:01:49","date_gmt":"2022-10-25T09:01:49","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-big-pharma-partnering-terms-and-agreements-analysis-report-2022-trends-in-dealmaking-in-the-biopharma-industry-since-2015-researchandmarkets-com\/"},"modified":"2022-10-25T11:01:49","modified_gmt":"2022-10-25T09:01:49","slug":"global-big-pharma-partnering-terms-and-agreements-analysis-report-2022-trends-in-dealmaking-in-the-biopharma-industry-since-2015-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-big-pharma-partnering-terms-and-agreements-analysis-report-2022-trends-in-dealmaking-in-the-biopharma-industry-since-2015-researchandmarkets-com\/","title":{"rendered":"Global Big Pharma Partnering Terms and Agreements Analysis Report 2022: Trends in Dealmaking in the Biopharma Industry Since 2015 &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/4495786\/global-big-pharma-partnering-terms-and-agreements?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=pbfsz8&amp;utm_campaign=1766336+-+Global+Big+Pharma+Partnering+Terms+and+Agreements+Analysis+Report+2022%3A+Trends+in+Dealmaking+in+the+Biopharma+Industry+Since+2015&amp;utm_exec=chdo54prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Global Big Pharma Partnering Terms and Agreements 2015-2022&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20221025005526\/en\/1612774\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20221025005526\/en\/1612774\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThe Global Big Pharma Partnering Terms and Agreements 2015-2022s report provides comprehensive access to available deals and contract documents for over 3,400 Big Pharma deals.\n<\/p>\n<p>\nThese deals tend to be multicomponent, starting with collaborative R&amp;D, and proceed to commercialization of outcomes. This report provides details of the latest Big Pharma agreements announced in the life sciences since 2015.\n<\/p>\n<p>\nThe report takes the reader through a comprehensive review Big Pharma deal trends, key players, top deal values, as well as deal financials, allowing the understanding of how, why and under what terms, companies are entering Big Pharma partnering deals.\n<\/p>\n<p>\nThe report presents financial deal term values for Big Pharma deals, listing by headline value, upfront payments, milestone payments and royalties, enabling readers to analyse and benchmark the financial value of deals.\n<\/p>\n<p>\nThe middle section of the report explores the leading dealmakers in the Big Pharma partnering field; both the leading deal values and most active Big Pharma dealmaker companies are reported allowing the reader to see who is succeeding in this dynamic dealmaking market.\n<\/p>\n<p>\nOne of the key highlights of the report is that over 3,400 online deal records of actual Big Pharma deals, as disclosed by the deal parties, are included towards the end of the report in a directory format &#8211; by company A-Z, stage of development, deal type, therapy focus, and technology type &#8211; that is easy to reference. Each deal record in the report links via Weblink to an online version of the deal.\n<\/p>\n<p>\nIn addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners. Whilst many companies will be seeking details of the payment clauses, the devil is in the detail in terms of how payments are triggered &#8211; contract documents provide this insight where press releases and databases do not.\n<\/p>\n<p>\nA comprehensive series of appendices is provided organized by Big Pharma partnering company A-Z, stage of development, deal type, and therapy focus. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each deal on demand.\n<\/p>\n<p>\nThe report also includes numerous tables and figures that illustrate the trends and activities in Big Pharma partnering and dealmaking since 2015.\n<\/p>\n<p>\nIn conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Big Pharma technologies and products.\n<\/p>\n<p>\n<strong>Report scope<\/strong>\n<\/p>\n<p>\n<strong>Big Pharma Partnering Terms and Agreements includes:<\/strong>\n<\/p>\n<ul>\n<li>\nTrends in Big Pharma dealmaking in the biopharma industry since 2015\n<\/li>\n<li>\nAccess to headline, upfront, milestone and royalty data\n<\/li>\n<li>\nAccess to Big Pharma contract documents\n<\/li>\n<li>\nLeading Big Pharma deals by value since 2015\n<\/li>\n<li>\nMost active Big Pharma dealmakers since 2015\n<\/li>\n<\/ul>\n<p>\n<strong>In Global Big Pharma Partnering Terms and Agreements 2015-2022, the available deals are listed by:<\/strong>\n<\/p>\n<ul>\n<li>\nCompany A-Z\n<\/li>\n<li>\nHeadline value\n<\/li>\n<li>\nStage of development at signing\n<\/li>\n<li>\nDeal component type\n<\/li>\n<li>\nSpecific therapy target\n<\/li>\n<li>\nTechnology type\n<\/li>\n<\/ul>\n<p>\n<strong>Analyzing actual contract agreements allows assessment of the following:<\/strong>\n<\/p>\n<ul>\n<li>\nWhat are the precise rights granted or optioned?\n<\/li>\n<li>\nWhat is actually granted by the agreement to the partner company?\n<\/li>\n<li>\nWhat exclusivity is granted?\n<\/li>\n<li>\nWhat is the payment structure for the deal?\n<\/li>\n<li>\nHow are sales and payments audited?\n<\/li>\n<li>\nWhat is the deal term?\n<\/li>\n<li>\nHow are the key terms of the agreement defined?\n<\/li>\n<li>\nHow are IPRs handled and owned?\n<\/li>\n<li>\nWho is responsible for commercialization?\n<\/li>\n<li>\nWho is responsible for development, supply, and manufacture?\n<\/li>\n<li>\nHow is confidentiality and publication managed?\n<\/li>\n<li>\nHow are disputes to be resolved?\n<\/li>\n<li>\nUnder what conditions can the deal be terminated?\n<\/li>\n<li>\nWhat happens when there is a change of ownership?\n<\/li>\n<li>\nWhat sublicensing and subcontracting provisions have been agreed?\n<\/li>\n<li>\nWhich boilerplate clauses does the company insist upon?\n<\/li>\n<li>\nWhich boilerplate clauses appear to differ from partner to partner or deal type to deal type?\n<\/li>\n<li>\nWhich jurisdiction does the company insist upon for agreement law?\n<\/li>\n<\/ul>\n<p>\n<strong>Key Topics Covered:<\/strong>\n<\/p>\n<p>\n<strong>Executive Summary<\/strong>\n<\/p>\n<p>\n<strong>Chapter 1 &#8211; Introduction<\/strong>\n<\/p>\n<p>\n<strong>Chapter 2 &#8211; Trends in Big Pharma dealmaking<\/strong>\n<\/p>\n<p>\n2.1. Introduction\n<\/p>\n<p>\n2.2. Big Pharma partnering over the years\n<\/p>\n<p>\n2.3. Most active Big Pharma dealmakers\n<\/p>\n<p>\n2.4. Big Pharma partnering by deal type\n<\/p>\n<p>\n2.5. Big Pharma partnering by therapy area\n<\/p>\n<p>\n2.6. Big Pharma partnering by technology type\n<\/p>\n<p>\n2.7. Deal terms for Big Pharma partnering\n<\/p>\n<p>\n2.7.1 Big Pharma partnering headline values\n<\/p>\n<p>\n2.7.2 Big Pharma deal upfront payments\n<\/p>\n<p>\n2.7.3 Big Pharma deal milestone payments\n<\/p>\n<p>\n2.7.4 Big Pharma royalty rates\n<\/p>\n<p>\n<strong>Chapter 3 &#8211; Leading Big Pharma deals<\/strong>\n<\/p>\n<p>\n3.1. Introduction\n<\/p>\n<p>\n3.2. Top Big Pharma deals by value\n<\/p>\n<p>\n<strong>Chapter 4 &#8211; Most active Big Pharma dealmakers<\/strong>\n<\/p>\n<p>\n4.1. Introduction\n<\/p>\n<p>\n4.2. Most active Big Pharma dealmakers\n<\/p>\n<p>\n4.3. Most active Big Pharma partnering company profiles\n<\/p>\n<p>\nIncluding Pfizer, Sanofi, Abbott, GlaxoSmithKline, Johnson &amp; Johnson and many others\n<\/p>\n<p>\n<strong>Chapter 5 &#8211; Big Pharma contracts dealmaking directory<\/strong>\n<\/p>\n<p>\n5.1. Introduction\n<\/p>\n<p>\n5.2. Big Pharma contracts dealmaking directory\n<\/p>\n<p>\n<strong>Chapter 6 &#8211; Big Pharma dealmaking by technology type<\/strong>\n<\/p>\n<p>\n<strong>Appendices<\/strong>\n<\/p>\n<p>\nAppendix 1 &#8211; Big Pharma deals by company A-Z\n<\/p>\n<p>\nAppendix 2 &#8211; Big Pharma deals by stage of development\n<\/p>\n<p>\nAppendix 3 &#8211; Big Pharma deals by deal type\n<\/p>\n<p>\nAppendix 4 &#8211; Big Pharma deals by therapy area\n<\/p>\n<p>\nAppendix 5 &#8211; Deal type definitions\n<\/p>\n<p>\nAppendix 6 &#8211; Further reading\n<\/p>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/4495786\/global-big-pharma-partnering-terms-and-agreements?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=pbfsz8&amp;utm_campaign=1766336+-+Global+Big+Pharma+Partnering+Terms+and+Agreements+Analysis+Report+2022%3A+Trends+in+Dealmaking+in+the+Biopharma+Industry+Since+2015&amp;utm_exec=chdo54prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/qlabn8<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#97;&#x69;&#x6c;&#116;&#111;&#x3a;&#x70;&#114;&#101;&#x73;&#x73;&#64;&#114;&#x65;&#x73;&#101;&#97;&#x72;&#x63;&#104;&#97;&#x6e;&#x64;&#109;&#97;&#x72;&#x6b;&#101;&#116;&#x73;&#x2e;&#99;&#111;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">p&#114;&#101;&#x73;&#x73;&#x40;r&#101;&#115;&#x65;&#x61;&#x72;ch&#97;&#x6e;&#x64;&#x6d;ar&#107;&#101;&#x74;&#x73;&#x2e;c&#111;&#109;<\/a><\/p>\n<p>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/ CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Big Pharma Partnering Terms and Agreements 2015-2022&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The Global Big Pharma Partnering Terms and Agreements 2015-2022s report provides comprehensive access to available deals and contract documents for over 3,400 Big Pharma deals. These deals tend to be multicomponent, starting with collaborative R&amp;D, and proceed to &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/global-big-pharma-partnering-terms-and-agreements-analysis-report-2022-trends-in-dealmaking-in-the-biopharma-industry-since-2015-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-50020","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Global Big Pharma Partnering Terms and Agreements Analysis Report 2022: Trends in Dealmaking in the Biopharma Industry Since 2015 - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/global-big-pharma-partnering-terms-and-agreements-analysis-report-2022-trends-in-dealmaking-in-the-biopharma-industry-since-2015-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Global Big Pharma Partnering Terms and Agreements Analysis Report 2022: Trends in Dealmaking in the Biopharma Industry Since 2015 - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Big Pharma Partnering Terms and Agreements 2015-2022&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The Global Big Pharma Partnering Terms and Agreements 2015-2022s report provides comprehensive access to available deals and contract documents for over 3,400 Big Pharma deals. These deals tend to be multicomponent, starting with collaborative R&amp;D, and proceed to ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/global-big-pharma-partnering-terms-and-agreements-analysis-report-2022-trends-in-dealmaking-in-the-biopharma-industry-since-2015-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-25T09:01:49+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221025005526\/en\/1612774\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-big-pharma-partnering-terms-and-agreements-analysis-report-2022-trends-in-dealmaking-in-the-biopharma-industry-since-2015-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-big-pharma-partnering-terms-and-agreements-analysis-report-2022-trends-in-dealmaking-in-the-biopharma-industry-since-2015-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Global Big Pharma Partnering Terms and Agreements Analysis Report 2022: Trends in Dealmaking in the Biopharma Industry Since 2015 &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-10-25T09:01:49+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-big-pharma-partnering-terms-and-agreements-analysis-report-2022-trends-in-dealmaking-in-the-biopharma-industry-since-2015-researchandmarkets-com\\\/\"},\"wordCount\":900,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-big-pharma-partnering-terms-and-agreements-analysis-report-2022-trends-in-dealmaking-in-the-biopharma-industry-since-2015-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221025005526\\\/en\\\/1612774\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-big-pharma-partnering-terms-and-agreements-analysis-report-2022-trends-in-dealmaking-in-the-biopharma-industry-since-2015-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-big-pharma-partnering-terms-and-agreements-analysis-report-2022-trends-in-dealmaking-in-the-biopharma-industry-since-2015-researchandmarkets-com\\\/\",\"name\":\"Global Big Pharma Partnering Terms and Agreements Analysis Report 2022: Trends in Dealmaking in the Biopharma Industry Since 2015 - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-big-pharma-partnering-terms-and-agreements-analysis-report-2022-trends-in-dealmaking-in-the-biopharma-industry-since-2015-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-big-pharma-partnering-terms-and-agreements-analysis-report-2022-trends-in-dealmaking-in-the-biopharma-industry-since-2015-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221025005526\\\/en\\\/1612774\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-10-25T09:01:49+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-big-pharma-partnering-terms-and-agreements-analysis-report-2022-trends-in-dealmaking-in-the-biopharma-industry-since-2015-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-big-pharma-partnering-terms-and-agreements-analysis-report-2022-trends-in-dealmaking-in-the-biopharma-industry-since-2015-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-big-pharma-partnering-terms-and-agreements-analysis-report-2022-trends-in-dealmaking-in-the-biopharma-industry-since-2015-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221025005526\\\/en\\\/1612774\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221025005526\\\/en\\\/1612774\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-big-pharma-partnering-terms-and-agreements-analysis-report-2022-trends-in-dealmaking-in-the-biopharma-industry-since-2015-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Global Big Pharma Partnering Terms and Agreements Analysis Report 2022: Trends in Dealmaking in the Biopharma Industry Since 2015 &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Global Big Pharma Partnering Terms and Agreements Analysis Report 2022: Trends in Dealmaking in the Biopharma Industry Since 2015 - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/global-big-pharma-partnering-terms-and-agreements-analysis-report-2022-trends-in-dealmaking-in-the-biopharma-industry-since-2015-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Global Big Pharma Partnering Terms and Agreements Analysis Report 2022: Trends in Dealmaking in the Biopharma Industry Since 2015 - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Big Pharma Partnering Terms and Agreements 2015-2022&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The Global Big Pharma Partnering Terms and Agreements 2015-2022s report provides comprehensive access to available deals and contract documents for over 3,400 Big Pharma deals. These deals tend to be multicomponent, starting with collaborative R&amp;D, and proceed to ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/global-big-pharma-partnering-terms-and-agreements-analysis-report-2022-trends-in-dealmaking-in-the-biopharma-industry-since-2015-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-10-25T09:01:49+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221025005526\/en\/1612774\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/global-big-pharma-partnering-terms-and-agreements-analysis-report-2022-trends-in-dealmaking-in-the-biopharma-industry-since-2015-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/global-big-pharma-partnering-terms-and-agreements-analysis-report-2022-trends-in-dealmaking-in-the-biopharma-industry-since-2015-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Global Big Pharma Partnering Terms and Agreements Analysis Report 2022: Trends in Dealmaking in the Biopharma Industry Since 2015 &#8211; ResearchAndMarkets.com","datePublished":"2022-10-25T09:01:49+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-big-pharma-partnering-terms-and-agreements-analysis-report-2022-trends-in-dealmaking-in-the-biopharma-industry-since-2015-researchandmarkets-com\/"},"wordCount":900,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-big-pharma-partnering-terms-and-agreements-analysis-report-2022-trends-in-dealmaking-in-the-biopharma-industry-since-2015-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221025005526\/en\/1612774\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/global-big-pharma-partnering-terms-and-agreements-analysis-report-2022-trends-in-dealmaking-in-the-biopharma-industry-since-2015-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/global-big-pharma-partnering-terms-and-agreements-analysis-report-2022-trends-in-dealmaking-in-the-biopharma-industry-since-2015-researchandmarkets-com\/","name":"Global Big Pharma Partnering Terms and Agreements Analysis Report 2022: Trends in Dealmaking in the Biopharma Industry Since 2015 - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-big-pharma-partnering-terms-and-agreements-analysis-report-2022-trends-in-dealmaking-in-the-biopharma-industry-since-2015-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-big-pharma-partnering-terms-and-agreements-analysis-report-2022-trends-in-dealmaking-in-the-biopharma-industry-since-2015-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221025005526\/en\/1612774\/21\/logo.jpg","datePublished":"2022-10-25T09:01:49+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/global-big-pharma-partnering-terms-and-agreements-analysis-report-2022-trends-in-dealmaking-in-the-biopharma-industry-since-2015-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/global-big-pharma-partnering-terms-and-agreements-analysis-report-2022-trends-in-dealmaking-in-the-biopharma-industry-since-2015-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/global-big-pharma-partnering-terms-and-agreements-analysis-report-2022-trends-in-dealmaking-in-the-biopharma-industry-since-2015-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221025005526\/en\/1612774\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221025005526\/en\/1612774\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/global-big-pharma-partnering-terms-and-agreements-analysis-report-2022-trends-in-dealmaking-in-the-biopharma-industry-since-2015-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Global Big Pharma Partnering Terms and Agreements Analysis Report 2022: Trends in Dealmaking in the Biopharma Industry Since 2015 &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50020","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=50020"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50020\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=50020"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=50020"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=50020"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}